BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22997857)

  • 21. [DNA methylation--alternative mechanism of chemical carcinogenesis].
    Kostka G; Urbanek K
    Rocz Panstw Zakl Hig; 2005; 56(1):1-14. PubMed ID: 16080440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
    Esteller M; Herman JG
    J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; CalabrĂ² L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-talk between aging and cancer: the epigenetic language.
    Fraga MF; Agrelo R; Esteller M
    Ann N Y Acad Sci; 2007 Apr; 1100():60-74. PubMed ID: 17460165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future potential of the Human Epigenome Project.
    Eckhardt F; Beck S; Gut IG; Berlin K
    Expert Rev Mol Diagn; 2004 Sep; 4(5):609-18. PubMed ID: 15347255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer epigenome.
    Lechner M; Boshoff C; Beck S
    Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic databases and computational methodologies in the analysis of epigenetic datasets.
    Ongenaert M
    Adv Genet; 2010; 71():259-95. PubMed ID: 20933132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.
    Valinluck V; Sowers LC
    Cancer Res; 2007 Jun; 67(12):5583-6. PubMed ID: 17575120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
    Koturbash I; Beland FA; Pogribny IP
    Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
    Wynter CV
    Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
    Shinjo K; Kondo Y
    Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acquired disorders and epigenetics].
    Ushijima T
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1645-9. PubMed ID: 20841925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic processes and cancer risk assessment.
    Preston RJ
    Mutat Res; 2007 Mar; 616(1-2):7-10. PubMed ID: 17147955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.